Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells.
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The cause of compensatory hyperinsulinemia in normogly- cemic insulin-resistant states is unknown.Using spontaneously hypertensive rats (SHR), we tested the hypothesis that a lowered a8-cell set-point for glucose causes a hypersecretion of insulin at a normal glucose level.Islets isolated from normoglycemic hyperinsulinemic SHR were compared to age-matched (12 wk old) Wistar-Kyoto (WK) rats.The ED5. for glucose-induced insulin secretion was 6.6±1.0 mM glucose in SHR versus 9.6±0.5 mM glucose in WK (P < 0.02).Glucokinase enzymatic activity was increased 40% in SHR islets (P < 0.02) without any change in the glucokinase protein level by Western blot.The level of the p-cell glucose transporter (GLUT-2) was increased 75% in SHR islets (P < 0.036).In summary, the P-cell sensitivity for glucose was in- creased in these normoglycemic insulin resistant rats by an enhanced catalytic activity of glucokinase.We have identi- fied a regulatory system for glucokinase in the p-cell which entails variable catalytic activity of the enzyme, is modulated in response to variations in whole-body insulin sensitivity, and is not dependent on sustained changes in the plasma glucose level.(J.Clin.Invest.1994.94:399-404.)Key words: insulin secretion * hexokinase * glucose metabolism * islets of Langerhans * GLUT-2 * glucose transporters in insulin secretion (4).The mechanism of the /3-cell hyper- function in euglycemic insulin resistant states is unexplained.Studies in insulin-resistant rat models have suggested a mechanism.The LAN-cp rats, Zucker fatty rats, and pregnant rats, all have lowered set-points for glucose-induced insulin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Parsons, J. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1459 · Cited by 476
Quantitative study of insulin secretion and clearance in normal and obese subjects
Polonsky, K. S., Given, B. D., Hirsch, L., Shapiro, E. T., Tillil, H., Beebe, C., Galloway, J. A., Frank, B. H., Karrison, T., & Van Cauter, E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113338 · Cited by 444
Cited by
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Islet β cell mass in diabetes and how it relates to function, birth, and death
Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296
A mathematical model of the pathogenesis, prevention, and reversal of type 2 diabetes
Ha, J., Satin, L. S., & Sherman, A. S. (2016) · Endocrinology · doi:10.1210/en.2015-1564 · Cited by 93
Giannocco, G., Oliveira, K. C., Crajoinas, R. O., Venturini, G., Salles, T. A., Fonseca-Alaniz, M. H., Maciel, R. M. B., & Girardi, A. C. C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.043 · Cited by 68
Metadata
- Authors
- Chen, C., Hosokawa, H., Bumbalo, L. M., & Leahy, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-07-01
- Volume
- 94
- Issue
- 1
- Pages
- 399-404
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2025603556
- Cited by
- 82
- References
- 4
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.